Bone Marrow Stem Cells Added to a Hydroxyapatite Scaffold Result in Better Outcomes after Surgical Treatment of Intertrochanteric Hip Fractures

Table 1

Flow cytometry analysis of the BM concentrate and aspirate.

	Cell viability	Total of nucleated cells	CD34^+ cells	Expected mesenchymal stem cells
BM concentrate	78% ± 0.3	2.1×10^7 cell/mL ± 0.1	8.2×10^4 cell/mL ± 0.3	200–2000 cell/mL
BM aspirate	51% ± 0.3	2.6×10^6 cell/mL ± 0.2	8.0×10^3 cell/mL ± 0.2	27–270 cell/mL